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Objectives: Amino acids and analogues thereof play an important role in the growth of many tumor cells. The 
clinical value of radiolabelled amino acids such as methionine, fluoroethyltyrosine and fluorodopa has been 
confirmed in a plethora of studies [1]. We sought to prepare, formulate and apply a metabolically stable analogue 
of the amino acid alanine for system A transport, namely [N-methyl-
11    
-methylamino-isobutyric acid, 
[
11
C]MeAIB [2]. 
Methods: The labelling precursor, [
11
C]MeOTf, was prepared on a Tracerlab FXc Pro by standard in-line gas-
phase conversions from [
11
C]CO2. The [
11
C]MeOTf was bubbled through a cooled solution of precursor in CH3OH, 
CH3CN and pentamethylpiperidine at 5 °C. The solution was warmed to 60 °C for 1 min, where 2 M NaOH was 
added. The heating was continued for 3 min. Shortly after, the mixture was automatically injected onto a 
semipreparative HPLC column via a 2 mL loop. 
 
 
Figure 1: Synthesis of [
11
C]MeAIB 
 
The HPLC purification was performed in aqueous, buffered CH3CN. Hence, the fraction containing the product 
was separated and diluted with 0.2 M H3PO4. This solution was loaded onto a Strata-X-C column, which was 
washed with sterile 0.1 M HCl and isotonic, sterile saline. The product was eluted with sterile 10 mL 2% Na2HPO4 
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-Foxn1
rnu
) were intracranially 
implanted in the right hemisphere with 300.000 low passage human glioblastoma single cells suspended in HBSS 
(Invitrogen) with 0.9% glucose (SAD 500 mg/mL). Four weeks post-implantation, rats with infiltrating 
glioblastomas were anesthetized and PET/CT scanned using a Siemens Inveon system after tail vein injection of 
[
11
C]MeAIB, [
11
C]methionine or [
18
F]FDG. Immediately after injection a dynamic acquisition was commenced. 
Results: The full synthesis of [
11
C]MeAIB including purification by prep. HPLC, solvent exchange by solid phase 
extraction and formulation takes about 35 min. delivering 2-5 GBq in 10 mL sterile phosphate-buffer. In all cases 
pH was maintained between 6.3-6.8 and the content of CH3CN was below 350 ppm. We have produced and more 
than 40 productions in the described manner. After administration to orthotopically implanted nude rats the 
glioblastoma were visualized with a tumor to background (normal brain) ratio for [
18
F]FDG, [
11
C]methionine and 
[
11
C]MeAIB of 1.5, 2.3 or 8.2, respectively.  
Conclusions: We have demonstrated the fast and reliable production of GMP-grade [
11
C]MeAIB. Also, 
[
11
C]MeAIB was successfully used in the imaging of human infiltrating glioblastoma in nude rats. [
11
C]MeAIB was 
found to have a significantly higher tumor to background ratio than [
11
C]methionine and [
18
F]FDG. 
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